Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004122
Status:
COMPLETED
Last Update Posted:
2013-02-01
First Post:
1999-12-10
Brief Title:
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute